© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 08, 2021
Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.
April 07, 2021
Empiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.
March 16, 2021
With a 1-hour infusion and lower infusion volume, oritavancin could minimize health system costs to treat these infections and improve efficiency in clinical practice.
March 15, 2021
The increasing prices of the drugs used to treat hookworm, roundworm (ascariasis), and whipworm (trichuriasis) is driving increased costs for patients with Medicaid or private insurance, as well as a potential decrease in the quality of care those patients receive.
February 19, 2021
Cost-conscious guidelines, government regulation, market-level incentives can ensure access, help patients save money.
December 21, 2020
The action allows for medicinal products to be authorized on a conditional basis for seriously debilitating or life-threatening diseases or for use in emergency situations in response to public health threats in the European Union.
December 11, 2020
Baloxavir marboxil and oseltamivir are options for treating uncomplicated influenza.
November 24, 2020
Originally approved in 2018, baloxavir marboxil is indicated for patients aged 12 years and older.
November 03, 2020
The new molecules are repurposed form a drug that’s been used for over 80 years.
October 27, 2020
The objective of the study was to investigate associations between symptoms of gastroenteritis and the presence of airborne norovirus, as well as investigating the size
of norovirus-carrying particles.